🔎 Trials Near Me

Почетна › Плоскоклеточни карцином главе и врата › Kalifornija

Kliničke studije za Плоскоклеточни карцином главе и врата u državi Kalifornija

75 studija za Плоскоклеточни карцином главе и врата traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • Kaiser Permanente-Anaheim, Anaheim
  • Kaiser Permanente-Bellflower, Bellflower
  • Kaiser Permanente Los Angeles Medical Center, Los Angeles
  • и још 1
Тражи се учесникФаза 2
Узраст од 18 до 79 · Оба пола · Ажурирано 12. 11. 2026. · NCT04671667

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Tower Cancer Research Foundation, Beverly Hills
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
  • и још 4
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05136196

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • VA Palo Alto Health Care System, Palo Alto
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06589804

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • City of Hope Comprehensive Cancer Center, Duarte
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07503808

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Oncura Health, Glendale
  • UC San Diego Health - Moores Cancer Center, La Jolla
  • California Research Institute, Los Angeles
  • и још 4
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • City of Hope National Medical Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • Administrative Address: UCLA Hematology/Oncology, Los Angeles
  • и још 3
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07090499

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • City of Hope National Medical Center, Duarte
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • Stanford Cancer Institute, Palo Alto
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06150664

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06992427

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Providence Medical Foundation (site 209), Santa Rosa
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT03556228

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

  • City of Hope, Duarte
Тражи се учесникФаза 1
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07219212

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  • Providence St Jude Medical Center, Fullerton
  • Scripps Health, La Jolla
  • Valkyrie Clinical Trials, Los Angeles
  • и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07276399

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  • City of Hope, Duarte
  • University of California at San Diego Moores Cancer Center, La Jolla
  • UCLA Hematology Oncology, Los Angeles
  • и још 1
Тражи се учесникФаза 3
Узраст 60 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT04892173

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • UCSD, La Jolla
  • Sharp Healthcare, San Diego
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT03526835

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • UC San Diego Moores Cancer Center (Site #0107), La Jolla
  • UCLA Department of Medicine - Hematology/Oncology (Site #0106), Los Angeles
  • UC Davis (Site#0144), Sacramento
  • и још 2
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06788990

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  • USA06-0, Los Angeles
  • USA16-0, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06953089

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

  • City of Hope Comprehensive Cancer Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07156227

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • City of Hope, Duarte
  • City of Hope, Irvine, Irvine
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

  • City of Hope Medical Center, Duarte
  • Los Angeles Cancer Network (LACN), Los Angeles
  • Medical Oncology Associates of San Diego, San Diego
  • и још 1
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06295731

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

  • Providence Medical Foundation, Fullerton
  • USC Norris Comprehensive Cancer Center, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06747585

A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT07744126

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Los Angeles Cancer Network, Los Angeles
  • Pih Health Hematology Medical Oncology, Whittier
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06330064

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06980038

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • University of California Los Angeles, Los Angeles
  • Samuel Oschin Cancer Center, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06769698

Intratumoral N17350 in Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
  • UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07339176

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 125, Los Angeles
  • Research Site 133, Los Angeles
  • Research Site 103, Los Angeles
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116

SMP-3124LP in Adults With Advanced Solid Tumors

  • Cedars Sinai Medical Center, Los Angeles
  • University of California, San Francisco, San Francisco
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT06526819

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

  • City of Hope National Medical Center /ID# 258645, Duarte
  • UCSF Medical Center - Mount Zion /ID# 257705, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06084481

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

  • Site 105 - START Los Angeles, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07462377

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06993844

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California Los Angeles Westwood Cancer Center, Los Angeles
  • Stanford Medicine - Cancer Center, Palo Alto
  • и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07768189

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Moores Cancer Center UC San Diego Health, La Jolla
  • Keck School of Medicine of USC, Los Angeles
  • UCLA, Los Angeles
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04429542

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #59, Santa Barbara
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05176483

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 9, La Jolla
  • ALX Center 11, Santa Monica
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT05877599

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Precision NextGen Oncology, Beverly Hills
  • OPN Healthcare, Inc, Glendale
  • University of Southern California, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06047379

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT07229313

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

  • Stanford University, Stanford
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT06736379

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Beverly Hills Cancer Center, Beverly Hills
  • City of Hope Cancer Center, Duarte
  • University of California Irvine Medical Center, Orange
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05983432

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.